MX2015013000A - Metodos de mantenimiento y mejora de la funcion muscular. - Google Patents
Metodos de mantenimiento y mejora de la funcion muscular.Info
- Publication number
- MX2015013000A MX2015013000A MX2015013000A MX2015013000A MX2015013000A MX 2015013000 A MX2015013000 A MX 2015013000A MX 2015013000 A MX2015013000 A MX 2015013000A MX 2015013000 A MX2015013000 A MX 2015013000A MX 2015013000 A MX2015013000 A MX 2015013000A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- muscle function
- maintenance
- improvement
- decrease
- Prior art date
Links
- 230000004220 muscle function Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000012423 maintenance Methods 0.000 title 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 abstract 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 abstract 1
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 abstract 1
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 abstract 1
- 101600082430 Homo sapiens Vascular endothelial growth factor A (isoform VEGF165) Proteins 0.000 abstract 1
- 108010056852 Myostatin Proteins 0.000 abstract 1
- 102300041083 Vascular endothelial growth factor A isoform VEGF165 Human genes 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B70/00—Preservation of non-alcoholic beverages
- A23B70/50—Preservation of non-alcoholic beverages by irradiation or electric treatment, without heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Se proporcionan métodos para disminuir la pérdida de función muscular y mejorar la función muscular en un sujeto. Los métodos utilizan una cantidad eficaz de epigalocatequina-3-galato (EGCg) para aumentar el nivel del factor de crecimiento endotelial vascular A (VEGF), para disminuir los niveles de miostatina, o ambos, y de ese modo disminuir la pérdida de la función muscular o mejorar la función muscular. El EGCg se puede proporcionar como parte de una composición nutricional.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361792489P | 2013-03-15 | 2013-03-15 | |
| US201361823832P | 2013-05-15 | 2013-05-15 | |
| PCT/US2014/028879 WO2014144458A1 (en) | 2013-03-15 | 2014-03-14 | Methods of maintaining and improving muscle function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015013000A true MX2015013000A (es) | 2015-12-01 |
Family
ID=50555279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015013000A MX2015013000A (es) | 2013-03-15 | 2014-03-14 | Metodos de mantenimiento y mejora de la funcion muscular. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9844531B2 (es) |
| EP (1) | EP2986158A1 (es) |
| JP (1) | JP2016517438A (es) |
| CN (1) | CN105431057A (es) |
| BR (1) | BR112015023031A2 (es) |
| CA (1) | CA2903565A1 (es) |
| HK (1) | HK1221611A1 (es) |
| MX (1) | MX2015013000A (es) |
| PH (1) | PH12015502167A1 (es) |
| SG (1) | SG11201507135XA (es) |
| WO (1) | WO2014144458A1 (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160361291A1 (en) * | 2013-12-18 | 2016-12-15 | Abbott Laboratories | Methods for increasing skeletal muscle protein synthesis using green tea extract |
| WO2016044272A1 (en) * | 2014-09-16 | 2016-03-24 | Abbott Laboratories | Methods of preserving muscle strength during a period of muscle disuse by administering beta-hydroxy-beta-methylbutyrate and green tea extract |
| WO2017057718A1 (ja) * | 2015-09-30 | 2017-04-06 | 協同乳業株式会社 | 難消化性成分を含む飲食品および大腸内水素ガス産生剤 |
| WO2017123922A1 (en) * | 2016-01-13 | 2017-07-20 | Metabolic Technologies, Inc. | COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) FOR JOINT STABILITY |
| AU2017270131B2 (en) * | 2016-05-27 | 2023-03-09 | Société des Produits Nestlé S.A. | Nutritional composition for treating or preventing impaired mobility |
| DK3528801T3 (da) * | 2016-10-21 | 2024-10-14 | Metabolic Tech Llc | Præparater og fremgangsmåder til anvendelse af beta-hydroxy-beta-methylbutyrat (HMB) og probiotika |
| US12370159B2 (en) | 2016-10-21 | 2025-07-29 | Metabolic Technologies, LLC | Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics |
| MX2019011725A (es) | 2017-03-31 | 2020-07-28 | Abbott Lab | Composiciones nutricionales liquidas que contienen aceite de pescado oxidable, acido rosmarinico y hierro ferrico. |
| WO2019027725A1 (en) | 2017-08-03 | 2019-02-07 | Abbott Laboratories | LIQUID NUTRITIONAL COMPOSITIONS COMPRISING GREEN TEA AND IRON EXTRACT |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| KR102281263B1 (ko) * | 2019-03-12 | 2021-07-26 | 주식회사 비티씨 | 갈릭산, 에피카테킨(ec), 및 에피갈로카테킨(egc)의 함량이 증가된 카테킨 효소처리물 및 이의 제조방법 |
| US20210228657A1 (en) * | 2019-04-23 | 2021-07-29 | Glac Biotech Co., Ltd. | Food composition and pharmaceutical composition used for increasing exercise performance and ameliorating fatigue |
| US20220241259A1 (en) * | 2019-07-05 | 2022-08-04 | Societe Des Produits Nestle S.A. | Compositions and methods using trigonelline and vitamins for preventing or treating conditions or disorders in skeletal muscle |
| US20220312818A1 (en) * | 2019-07-25 | 2022-10-06 | Korea University Research And Business Foundation | Preparation method for two-spotted cricket powder or extract thereof, food composition comprising same, and uses of same |
| CN115279199A (zh) | 2019-11-11 | 2022-11-01 | 阿拉食品公司 | 富含多酚的高蛋白含胶束酪蛋白营养液及其生产方法 |
| CN111000233A (zh) * | 2019-11-28 | 2020-04-14 | 湖南农业大学 | Ecg作为健肌功能成分的应用 |
| CN110839890B (zh) * | 2019-12-03 | 2022-06-21 | 湖南农业大学 | 一种茶黄素健肌的膳食营养补充剂的及其制备方法 |
| CA3175049A1 (en) * | 2020-03-10 | 2021-04-15 | The Regents Of The University Of California | Novel nutrients to enhance load-induced muscle hypertrophy |
| KR20220015769A (ko) * | 2020-07-31 | 2022-02-08 | 고려대학교 산학협력단 | 그릴루스 비마쿨라투스를 유효성분으로 포함하는 근위축증의 예방, 개선 또는 치료용 조성물 |
| WO2025030001A2 (en) * | 2023-08-02 | 2025-02-06 | Abbott Laboratories | Methods and compositions for maintaining skeletal muscle mobility and/or mass, and/or for recovery of skeletal muscle strength |
| WO2025243299A1 (en) * | 2024-05-20 | 2025-11-27 | Technion Research & Development Foundation Limited | Nutrient-based formulations usable in treating muscle atrophy |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001516343A (ja) | 1997-02-21 | 2001-09-25 | アボツト・ラボラトリーズ | 壊死性全腸炎の発生を減少させるための方法及び組成物 |
| US6365218B1 (en) | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
| US6811801B2 (en) | 2001-12-12 | 2004-11-02 | Abbott Laboratories | Methods and compositions for brightening the color of thermally processed nutritionals |
| MXPA04006039A (es) | 2001-12-19 | 2004-09-27 | The Quigley Corp | Metodo para el tratamiento de afecciones vasculares y neuronales perifericas. |
| US7108868B2 (en) | 2002-03-22 | 2006-09-19 | Unigen Pharmaceuticals, Inc. | Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| MXPA05002648A (es) | 2002-09-16 | 2005-08-19 | Wyeth Corp | Activacion de miostatina por metaloproteasa, y metodos para modular la actividad de miostatina. |
| US7083813B2 (en) | 2002-11-06 | 2006-08-01 | The Quigley Corporation | Methods for the treatment of peripheral neural and vascular ailments |
| JP2006131512A (ja) | 2004-11-02 | 2006-05-25 | Pharma Foods International Co Ltd | アディポネクチン分泌促進組成物および該組成物を含有する飲食品 |
| FR2882896B1 (fr) | 2005-03-14 | 2007-05-04 | Larena Sa | Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees |
| CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| ATE537819T1 (de) * | 2005-10-14 | 2012-01-15 | Dsm Ip Assets Bv | Nutrazeutische zusammensetzungen zur behandlung von muskelschwund |
| US20090163579A1 (en) | 2005-10-14 | 2009-06-25 | Daniel Raederstorff | Novel use of nutraceutical compositions |
| WO2007053929A1 (en) * | 2005-11-08 | 2007-05-18 | Accelis Formulations Ltd. | Diet supplement and method for weight-loss |
| KR101558231B1 (ko) | 2006-05-01 | 2015-10-08 | (주)아모레퍼시픽 | (-)카테친을 함유하는 아디포넥틴 발현 증강제 |
| JP2009536667A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス，インコーポレイティド | ５ｈｔ受容体介在性の神経新生 |
| US7858611B2 (en) | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
| JP2008013473A (ja) * | 2006-07-05 | 2008-01-24 | Kao Corp | 筋機能低下抑制剤 |
| WO2008004340A1 (en) | 2006-07-05 | 2008-01-10 | Kao Corporation | Senescence inhibitor |
| US20090197944A1 (en) | 2006-07-05 | 2009-08-06 | Kao Corporation | Agent for improving muscle force |
| EP1961310A1 (en) * | 2007-02-01 | 2008-08-27 | DSMIP Assets B.V. | Novel use of (-) -epigallocatechin gallate |
| US20100210692A1 (en) | 2007-03-28 | 2010-08-19 | Farmer Stephen R | Methods of treatment using sirt modulators and compositions containing sirt1 modulators |
| EP2170338A2 (en) * | 2007-07-06 | 2010-04-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dna-pkcs modulates energy regulation and brain function |
| RS55735B1 (sr) | 2007-08-03 | 2017-07-31 | Summit (Oxford) Ltd | Kombinacije lekova za lečenje dišenove mišićne distrofije |
| JP2009120491A (ja) | 2007-11-12 | 2009-06-04 | Tsujido Kagaku Kk | アディポネクチン産生促進剤 |
| EP2219602A1 (en) | 2007-11-15 | 2010-08-25 | Amgen, Inc | Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration |
| WO2010118419A2 (en) | 2009-04-10 | 2010-10-14 | Haiyan Qi | Novel anti-aging agents and methods to identify them |
| US20100303937A1 (en) | 2009-06-01 | 2010-12-02 | Michael Farber | Novel composition to increase testosterone levels |
| EP2440201A1 (en) | 2009-06-10 | 2012-04-18 | Energy4life Ag | Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders |
| CA2768471A1 (en) | 2009-07-20 | 2011-01-27 | Nestec S.A. | Methods of attenuating the loss of functional status |
| WO2011089620A2 (en) | 2010-01-25 | 2011-07-28 | Concept Medical Research Private Limited | A method and an insert able medical device for delivering one or more pro-healing agents to a target site within a blood vessel post-deployment of a stent |
| US9901564B2 (en) | 2012-03-23 | 2018-02-27 | Cardero Therapeutics, Inc. | Compounds and compositions for the treatment of muscular disorders |
| WO2014028607A1 (en) | 2012-08-14 | 2014-02-20 | Abbott Laboratories | Low glycemic index nutritional compositions for preserving muscle mass and improving body composition in diabetics |
| CN104837369B (zh) | 2012-10-04 | 2017-03-08 | 雅培制药有限公司 | 用于增强EGCg对减缓骨骼肌损失的作用的方法 |
-
2014
- 2014-03-14 BR BR112015023031A patent/BR112015023031A2/pt not_active IP Right Cessation
- 2014-03-14 US US14/776,972 patent/US9844531B2/en not_active Expired - Fee Related
- 2014-03-14 SG SG11201507135XA patent/SG11201507135XA/en unknown
- 2014-03-14 JP JP2016502929A patent/JP2016517438A/ja active Pending
- 2014-03-14 CA CA2903565A patent/CA2903565A1/en not_active Abandoned
- 2014-03-14 EP EP14719586.1A patent/EP2986158A1/en not_active Withdrawn
- 2014-03-14 CN CN201480027811.9A patent/CN105431057A/zh active Pending
- 2014-03-14 MX MX2015013000A patent/MX2015013000A/es unknown
- 2014-03-14 WO PCT/US2014/028879 patent/WO2014144458A1/en not_active Ceased
- 2014-03-14 HK HK16109947.7A patent/HK1221611A1/zh unknown
-
2015
- 2015-09-15 PH PH12015502167A patent/PH12015502167A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20160038457A1 (en) | 2016-02-11 |
| HK1221611A1 (zh) | 2017-06-09 |
| JP2016517438A (ja) | 2016-06-16 |
| WO2014144458A1 (en) | 2014-09-18 |
| CN105431057A (zh) | 2016-03-23 |
| BR112015023031A2 (pt) | 2017-07-18 |
| SG11201507135XA (en) | 2015-10-29 |
| CA2903565A1 (en) | 2014-09-18 |
| PH12015502167A1 (en) | 2016-01-25 |
| EP2986158A1 (en) | 2016-02-24 |
| US9844531B2 (en) | 2017-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015013000A (es) | Metodos de mantenimiento y mejora de la funcion muscular. | |
| CL2023000198A1 (es) | Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo | |
| MX2021008901A (es) | Compuestos conjugados antisentido y su uso. | |
| DOP2015000246A (es) | Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares | |
| HRP20182179T1 (hr) | 2,3-disupstituirani 1-acil-4-amino-1,2,3,4-tetrahidrokonolin derivati i njihova uporaba kao inhibitora bromodomena | |
| MX2016013166A (es) | Protectores de transferencia de transportador. | |
| MX391963B (es) | Beta-caseina a2 y prevencion de la inflamacion del intestino. | |
| DK3126217T3 (da) | Redningspakke, der er udfoldelig i luften | |
| CR20150440A (es) | Nuevos derivados de piridina | |
| PH12015502319A1 (en) | Methods for enhancing aged muscle regeneration | |
| HRP20181248T1 (hr) | Glioksalirani kopolimeri poliakrilamida s velikom molekulskom masom i velikim kationskim nabojem, te postupci njihove proizvodnje i uporabe | |
| GT201400061S (es) | Diseño de motocicleta | |
| CR20150511A (es) | Nuevos derivados de purina | |
| DOP2015000298A (es) | Compuestos nuevos para el tratamiento del cáncer | |
| MX2020003049A (es) | Semaglutida en la terapia medica. | |
| PL3393329T3 (pl) | Zmywarka do naczyń z urządzeniem podnoszącym i sposób użytkowania urządzenia podnoszącego | |
| PT2820953E (pt) | Estirpe de glomus iranicum var. tenuihypharum var. nov. e sua utilização como bioestimulante | |
| MX2015009277A (es) | Formas de dosificacion y usos terapauticos de l-4-cloro quinurenina. | |
| LT3229790T (lt) | Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme | |
| PH12017500084A1 (en) | Vitamin b2 and its use | |
| AR097111A1 (es) | Combinación y método para la administración a un animal | |
| PL2821478T3 (pl) | Szczep Glomus iranicum var. tenuihypharum var. nov. i jego zastosowanie jako bio-nematocyd | |
| CO7160058A2 (es) | Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis | |
| Tatishvili | The Hymn of Anthon Catholicos dedicated to St. Nino | |
| CR20140456S (es) | Grúa de pórtico |